Official scientific distribution organ of Instituto Panvascular de Occidente
Meningoencefalitis Criptocócica: Un Reporte de Caso
PDF Reporte de Caso (Spanish)

Keywords

Meningoencephalitis
Cryptococcus neoformans
Neuroinfection
Fungus

Categories

How to Cite

1.
Meningoencefalitis Criptocócica: Un Reporte de Caso. Rev Med Clin [Internet]. 2025 Apr. 17 [cited 2025 Jul. 22];9(1):e17042509007. Available from: https://medicinaclinica.org/index.php/rmc/article/view/639

Abstract

Introduction: Cryptococcus is an encapsulated yeast with opportunistic capabilities, responsible for severe infections such as meningoencephalitis and disseminated cryptococcosis. The most relevant species are Cryptococcus neoformans and Cryptococcus gatti; the former mainly inmunosuppressed individuals, while the latter can infect immunocompetent individuals. The infection occurs through the respiratory route, usually asymptomatically or with mild symptoms; however, in individuals with a weakened immune system, the fungus can spread to the central nervous system. Case Report: This is the case of a male patient with a history of ischemic cerebrovascular event and type 2 diabetes mellitus who presented with headache, predominantly holocranial, nausea, vomiting, disorientation, and impaired consciousness. Brain MRI showed a lesion with increased intensity in the right lateral ventricle. A lumbar puncture was performed with results suggestive of fungal meningitis. Subsequently, the cerebrospinal fluid culture was positive for Cryptococcus neoformans using India ink and showed growth of this pathogen on Sabouraud dextrose agar. Treatment with amphotericin B and 5-flucytosine was initiated; however, the patient developed complications that ultimately led to his death Conclusions: Cryptococcal meningoencephalitis is a condition with high mortality. Therefore, finding suggestive signs in the central nervous system should be an indicator to initiate intensive treatment regimens that can impact the patient's prognosis.



PDF Reporte de Caso (Spanish)

References

Talwar S, Maldar S, Mudda A, J Pinto C, Julovich A. Diagnosis of Dyke-Davidoff-Masson syndrome in an adult. Radiol Case Rep [Internet]. 2024 Dec;19(12):6241–5. https://doi.org/10.1016/j.radcr.2024.08.098

Dary Caicedo Bejarano LD, Álvarez MI. Crecimiento del complejo Cryptococcus neoformans/Cryptococcus gattii en extractos de excretas de palomas. Entramado. 2019 Dec 30;16(1):218–29. https://doi.org/10.18041/1900-3803/entramado.1.6087

Villafuerte DB, Passeri MF, Qazi R, Baireddy M, Sanchez FL. Transverse Myelitis Associated with Cryptococcus neoformans in an Immunocompetent Patient. Case Rep Infect Dis. 2022 Feb 21;2022:1–5. https://doi.org/10.1155/2022/2000246

Cumagun PM, Moore MK, McCarty TP, McGwin G, Pappas PG. Cryptococcal Meningoencephalitis in Phenotypically Normal Patients. Vol. 12, Pathogens. Multidisciplinary Digital Publishing Institute (MDPI); 2023. https://doi.org/10.3390/pathogens12111303

Phadke R V., Agarwal V, Naik S. Multicystic encephalomalacia secondary to head trauma. Vol. 8, Journal of Neurosciences in Rural Practice. Medknow Publications; 2017. p. 158–9. https://doi.org/10.4103/0976-3147.193537

Katchanov J, Branding G, Jefferys L, Arastéh K, Stocker H, Siebert E. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution. Int J STD AIDS. 2016 Feb 1;27(2):110–7. https://doi.org/10.1177/0956462415574633

Maziarz EK, Perfect JR. Cryptococcosis. Vol. 30, Infectious Disease Clinics of North America. W.B. Saunders; 2016. p. 179–206. https://doi.org/10.1016/j.idc.2015.10.006

Castañeda E, Lizarazo J. Protocolo de estudio y manejo de los pacientes con criptococosis A protocol for the study and management of patients with cryptococcosis. 2012;16:123–5. https://www.elsevier.es/es-revista-infectio-351-articulo-protocolo-estudio-manejo-pacientes-con-S0123939212700383

Correction to Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM (The Lancet Infectious Diseases (2021) 21(12) (e375–e386), (S1473309921002036), (10.1016/S1473-3099(21)00203-6)). Vol. 24, The Lancet Infectious Diseases. Elsevier Ltd; 2024. p. e485. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00426-2/fulltext

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2025 Sergio González-Ramírez

Downloads

Download data is not yet available.